Goldman Sachs Raises PT on Abbvie (ABBV) to $52 – StreetInsider.com (subscription)
Goldman Sachs Raises PT on Abbvie (ABBV) to $52StreetInsider.com (subscription)For example, key pipeline assets in Hep C, elagolix and daclizumab could generate over $5.5 bn at peak (exhibit 1) while we have only $3.3 bn in our total 2020 pipeline esti…

